Search Results - SONEGO, HAGAR

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy

    M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy by Fisher, Abraham, Pittel, Zipora, Haring, Rachel, Bar-Ner, Nira, Kliger-Spatz, Michal, Natan, Niva, Egozi, Inbal, Sonego, Hagar, Marcovitch, Itzhak, Brandeis, Rachel

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells

    The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells by Aharoni, Rina, Sonego, Hagar, Brenner, Ori, Eilam, Raya, Arnon, Ruth

    Published in Immunology Letters
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Anticholinergic and Antiglutamatergic Agents Protect against Soman-Induced Brain Damage and Cognitive Dysfunction

    Anticholinergic and Antiglutamatergic Agents Protect against Soman-Induced Brain Damage and Cognitive Dysfunction by Raveh, Lily, Brandeis, Rachel, Gilat, Eran, Cohen, Giora, Alkalay, David, Rabinovitz, Ishai, Sonego, Hagar, Weissman, Ben Avi

    Published in Toxicological sciences
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Caramiphen and Scopolamine Prevent Soman-Induced Brain Damage and Cognitive Dysfunction

    Caramiphen and Scopolamine Prevent Soman-Induced Brain Damage and Cognitive Dysfunction by Raveh, Lily, Weissman, Ben Avi, Cohen, Giora, Alkalay, David, Rabinovitz, Ishai, Sonego, Hagar, Brandeis, Rachel

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease

    AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease by Fisher, Abraham, Brandeis, Rachel, Bar-Ner, Rachel Haring Nira, Kliger-Spatz, Michal, Natan, Niva, Sonego, Hagar, Marcovitch, Itzhak, Pittel, Zipora

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  6. 6
    Monitoring Drug-Induced Neurodegeneration by Imaging of Peripheral Benzodiazepine Receptors

    Monitoring Drug-Induced Neurodegeneration by Imaging of Peripheral Benzodiazepine Receptors by WEISSMAN, BEN AVI, BRANDEIS, RACHEL, GILAT, ERAN, COHEN, GIORA, ALKALAY, DAVID, RABINOVITZ, ISHAI, SONEGO, HAGAR, RAVEH, LILY

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer’s disease

    M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer’s disease by Fisher, Abraham, Pittel Zipora, Haring, Rachel, Bar-Ner Nira, Kliger-Spatz Michal, Natan Niva, Egozi Inbal, Hagar, Sonego, Marcovitch Itzhak, Brandeis, Rachel

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: